MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials.

Barkhof F, Simon JH, Fazekas F, Rovaris M, Kappos L, De Stefano N, Polman CH, Petkau J, Radue EW, Sormani MP, et al.